UnknownPhase 2/3

Probiotics in Pediatric Chronic Cholestasis

Indonesia60 participantsStarted 2020-09-01

Plain-language summary

double blinded RCT (probiotics vs placebo) given to pediatric patients with chronic cholestasis for 4 weeks duration. baseline characteristics (antropometry, gastrointestinal symptoms, laboratory examinations) would be compared pre vs post treatment

Who can participate

Age range29 Days – 215 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed with chronic cholestasis (\>4 weeks evidence of cholestasis from laboratory evidence) * patient/guardian give consent to participate Exclusion Criteria: * immunocompromised * consumed antibiotic within 2 weeks prior to recruitment time * patient already consuming probiotic-added formula (any probiotic supplementation or formula milk with added probiotic)